590 filings
SC 13G/A
Adage Capital Partners GP, L.L.C.
7 Feb 24
9 METERS BIOPHARMA / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
7:40am
25-NSE
NMTRQ
9 Meters Biopharma, Inc.
8 Sep 23
Exchange delisting
10:11am
144
Bethany Sensenig
21 Jul 23
Notice of proposed sale of securities
4:22pm
144
NMTRQ
9 Meters Biopharma, Inc.
19 Jul 23
Notice of proposed sale of securities
4:41pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
18 Jul 23
Entry into a Material Definitive Agreement
8:00am
8-K
NMTRQ
9 Meters Biopharma, Inc.
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
30 May 23
9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
4:11pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
22 May 23
Other Events
8:05am
PRE 14A
NMTRQ
9 Meters Biopharma, Inc.
Preliminary proxy
19 May 23
8:07am
8-K
NMTRQ
9 Meters Biopharma, Inc.
19 May 23
Entry into a Material Definitive Agreement
8:02am
10-Q
2023 Q1
NMTRQ
9 Meters Biopharma, Inc.
Quarterly report
15 May 23
5:18pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
15 May 23
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023
5:16pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
27 Apr 23
Entry into a Material Definitive Agreement
8:17am
144
NMTRQ
9 Meters Biopharma, Inc.
21 Apr 23
Notice of proposed sale of securities
5:16pm
4
Bethany Sensenig
21 Apr 23
9 METERS BIOPHARMA / Bethany Sensenig ownership change
5:08pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
6 Apr 23
Entry into a Material Definitive Agreement
4:15pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
5 Apr 23
9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding its GIP Antagonist NM-136 for Obesity
8:31am
4
NMTRQ
9 Meters Biopharma, Inc.
31 Mar 23
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:35pm
4
Yehuda Michael Rice
31 Mar 23
9 METERS BIOPHARMA / YEHUDA MICHAEL RICE ownership change
4:28pm